Acute Leukemias - Republican Scientific Medical Library

Subject Index
A
aberrant methylation 240
ABL gene 99
ABL protein 179
– wild-type 179
abnormalities TAL-1/2 gene 126
acidosis 283
activated partial thromboplastin time
(aPTT) 284
acute lymphoblastic leukemia 218, 275, 277
acute lymphoblastic leukemia (ALL) 28, 77,
95, 131, 137, 145, 215, 229, 247, 263, 281
– cytogenetic aberrations 95
acute lymphoblastic leukemias (ALL) 191
acute lymphocytic leukemia (ALL) 47
acute myeloid leucemia (AML) 1
– complete remission (CR) 2
acute myeloid leukemia (AML) 97
acute promyelocytic leukemia, hematopoietic
stem cell transplantation 68
acute promyelocytic leukemia (APL) 22, 52,
58, 66
– arsenic trioxide 67
acute tumor lysis syndrome (ATLS) 281
ADA, see adenosine deaminase 64
adenosine deaminase (ADA) 64
adriamycin 146
Affymetrix 39–40, 101
AHD, see antecedent hematologic
disorder 3
air pollution 87
alemtuzumab 133–134, 242
alkylating agents 52
all trans-retinoic acid (ATRA) 33
ALL, acute lymphoblastic leukemia 28
ALL, see acute lymphoblastic leukemia 77,
82–83, 95, 109, 111, 149, 161, 180, 229, 238,
247, 251, 263, 233, 277
– (FAB) classification 119
– age 80
– aplastic and hypoplastic 122
– B-cell 122
– B-lineage 115
– BCR/ABL-positive 96
– bone marrow biopsies 111
– bone marrow transplant 276
– Burkitt cell 191
– Burkitt-like (atypical Burkitt) 122
– CALGB studies 137
– central nervous system (CNS) involvement
263
– childhood 181
– classification 110, 181
– clinical presentation 110
– CNS-positive 149
– complete remission (CR) 131, 137, 146
– complete responses (CRs) 275
– cytogenetic abnormalities 83
– cytogenetic analysis 116
– cytomorphology 110
– diagnosis 110, 119
– diet 88
– elderly patients 152
– epidemiology 109
– etiology 82
– FLT3-positive ALL 102
– gender 80
– GMALL studies 168
– hematopoietic stem cell transplantation
(SCT) 215
– high hyperdiploidy 124
– hyper-CVAD regimen 162
– hyperdiploidy 124
– immunophenotyping 113
– in childhood 125, 180, 251
– incidence 78, 109
– LALA group 145
– liposomal preparations 238
– maintenance therapy 233
– mediastinal mass 284
– metabolic complications 281
– minimal residual disease (MRD) 247
– mortality 80
– MPO-positive 123
– natural killer cell phenotype 123
– negativity 120
– neurological complications 285
– nonspecific esterase (NSE) 120
– numerical aberrations 100
– organ involvement 286
– ph-positive 164
– Philadelphia chromosome (Ph)-positive
216
– Philadelphia chromosome positive 116,
124
– Philadelphia chromosome-positive 149,
151, 177, 218
– – treatment 180
– Philadelphia-chromosome positive 277
– Philadelphia-chromosome-positive 133
– precursor B-cell 84
– precursor-B phenotype 115
– presentation 109
– race 80
– relapse 275
– risk model 175
– salvage therapy 238
– smoking 88
– socioeconomic status (SES) 82
– stem cell transplantation (SCT) 229
– structural aberrations 96
– survival 78
– T lineage 115
– T-cell 99, 102, 122
– TEL-AML1-positive 84
– treatment 131, 161, 180
– with eosinophilia 122
all-trans retinoic acid (ATRA) 58